Intuitive Surgical reported strong Q3 results, beating both revenue and EPS estimates, driven by significant growth in procedure volume and system placements. Despite the beat, the stock tumbled over 10% after hours, likely due to the company's full-year 2026 guidance for da Vinci procedures, which, while positive, may have disappointed some investors expecting a larger increase or due to broader market sentiment.
Intuitive Surgical delivered a strong third quarter, surpassing analyst expectations for both revenue and earnings per share, fueled by robust growth in surgical procedures and system installations. This performance typically would lead to a positive market reaction. However, the stock experienced a significant after-hours decline, suggesting that while the Q3 numbers were good, the forward-looking guidance for 2026 da Vinci procedures, even with a slight increase in the lower bound, might have fallen short of aggressive investor expectations or was overshadowed by broader market concerns. This creates a short-term trading opportunity for those looking to capitalize on potential overreactions or a long-term opportunity for those who believe the underlying business strength will prevail.